Print this page    •   Back to Web version of article

The Global HIV/AIDS Epidemic

By Kimberly Page-Shafer, PhD, MPH

Summer 2000

Table of Contents:


EarthAt the close of this past decade, an estimated 33.6 million men, women, and children worldwide were infected with the human immunodeficiency virus (HIV). This virus, unknown until 17 years ago, now dominates national and international affairs. The HIV/AIDS epidemic is now acknowledged to be a contributing factor to changing national economies, to population displacement, and most recently, to national and international security.

The following list highlights key findings from the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) as of December 1999.

Regional HIV/AIDS Statistics and Features,
December 1998
  Epidemic started Adults & children living with HIV/AIDS Adults & children newly infected with HIV Adult prevalence rate [1] % HIV-
positive women
Main mode of transmission for those living with HIV/AIDS [2]
Sub-
Saharan Africa
late 70s-
early 80s
22.5
million
4.0
million
8.0%50%Heterosexual
North Africa & Middle Eastlate 80s210,00019,0000.13%20%IDU, Heterosexual
South & South-
East Asia
late 80s6.7
million
1.2
million
0.69%25%Heterosexual
East Asia & Pacificlate 80s560,000200,0000.068%15%IDU, Heterosexual, MSM
Latin Americalate 70s-
early 80s
1.4
million
160,0000.57%20%MSM, IDU, Heterosexual
Caribbeanlate 70s-
early 80s
330,00045,0001.96%35%Heterosexual, MSM
Eastern Europe & Central Asiaearly 90s270,00080,0000.14%20%IDU, MSM
Western Europelate 70s-
early 80s
500,00030,0000.25%20%MSM, IDU
North Americalate 70s-
early 80s
890,00044,0000.56%20%MSM, IDU, Heterosexual
Australia & New Zealandlate 70s-
early 80s
12,0006000.1%5%MSM, IDU
Total 33.4 million5.8 million1.1% average43% average 
  1. The proportion of adults (15-49 years of age) living with HIV/AIDS in 1998, using 1997 population numbers
  2. IDU: transmission through injection drug use; MSM: sexual transmission among men who have sex with men


Introduction

Twenty years into the HIV/AIDS epidemic, much is known about preventing HIV infection. Yet the epidemic continues and is in fact unrelenting in some places. Worldwide, surveillance and prevention responses vary as a result of many factors.

This article cannot provide a full description of all aspects of the epidemic in every country or the vast and diverse range of cultural, social, environmental, biological, and even political dynamics of this devastating epidemic. Instead, this article will provide a snapshot of some of that diversity and range by describing the epidemiology (i.e., frequency, distribution, and behavior) of HIV in a few representative regions and countries.

The HIV/AIDS epidemic is fraught with paradox and true drama: life-saving treatments bring hope as well as risk; countries that share borders have vastly different epidemics. HIV has changed the world and is still changing it.


Antiretroviral Therapies Significantly Impact Mortality

The numbers of new AIDS cases and AIDS deaths are both falling significantly in countries that provide antiretroviral therapy for a majority of those diagnosed with HIV. However, there is no sign that new HIV infections are following the same downward course. On the contrary, extremely worrying recent evidence suggests that the advent of life-prolonging therapies may have led to complacency among some groups of people about the dangers of HIV, and that that complacency may be leading to rises in risky behavior.

For the past several years in San Francisco, for example, there have been decreases in the number of men who have sex with men (MSM) reporting consistent condom use, increases in the number of men reporting unprotected anal sex with multiple partners, and increases in rectal gonorrhea. Many of the men sampled in these studies reported that they did not know their partners' HIV status. Of particular concern is that the absolute number of HIV positive people is probably growing because of improved survival.

Theoretically, antiretroviral therapy could reduce a person's infectiousness, or the likelihood that an infected person might pass on the virus to a sexual partner. Evidence of this effect is not conclusive, but some new research has demonstrated reduced transmission in a study of serodiscordant heterosexual couples (i.e., those in which only one partner is HIV positive). On the other hand, even if a person's overall infectiousness is reduced by anti-HIV drugs, there is good evidence that viable virus (i.e., virus capable of reproducing) can be recovered from seminal fluid in men taking highly active antiretroviral therapy, or HAART.

Yet until further studies of HIV treatment and infectivity are done, it must be assumed that a higher level of HIV in the pool of potential sexual partners means a higher risk of transmission whenever unprotected sex occurs with a partner of unknown HIV status. More than ever, prevention leaders, community-based organizations, and public health officials must continue to pursue effective HIV prevention efforts in communities where HIV incidence (number of new infections) has declined and prevalence (infection levels) is stable or increasing.


Next | Table of Contents


Back to the SFAF BETA Summer, 2000 contents page.




This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art2625.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.